Neogenomics Inc. NEO

What this company does

NeoGenomics, Inc. provides oncology diagnostic testing and consultative services, including technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts who specialize in pathology and oncology. As of December 31, 2025, it operated College of American Pathologists accredited and Clinical Laboratory Improvement Amendments of 1988 certified laboratories in Fort Myers, Florida; Aliso Viejo and Carlsbad, California; Durham, North Carolina; Ramsey, New Jersey; and Houston, Texas; and an International Organization for Standardization certified, CAP accredited full-service, sample-processing laboratory in Cambridge, United Kingdom. It operates under a single segment that encompasses a comprehensive range of services, serving a client base that includes community-based pathology and oncology practices, hospital pathology labs, reference labs, academic centers, and pharmaceutical companies. As of December 31, 2025, it had approximately 2,500 full-time equivalent employees, including contracted pathologists. For the years ended December 31, 2025, 2024 and 2023, no single client accounted for more than 10% of its revenue.

Written from the business description in NEOGENOMICS, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 17 February 2026. Every sentence was checked against that document before publication.